• Quanterix Corp QTRX.OQ reported a quarterly adjusted loss of 57 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -25 cents. The mean expectation of four analysts for the quarter was for a loss of 36 cents per share. Wall Street expected results to range from -41 cents to -30 cents per share.

• Revenue fell 28.8% to $24.48 million from a year ago; analysts expected $28.23 million.

• Quanterix Corp's reported EPS for the quarter was a loss of 77 cents​.

• The company reported a quarterly loss of $30.01 million.

• Quanterix Corp shares had fallen by 17.1% this quarter and lost 48.2% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 11.8% in the last three months.​

• In the last 30 days, two analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

• Wall Street's median 12-month price target for Quanterix Corp is $8.00, about 31.1% above its last closing price of $5.51

This summary was machine generated from LSEG data August 8 at 05:30 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)